Question 1

What are the most cited papers from AlzeCure Pharma (Sweden)?

Accepted Answer

The most cited paper from AlzeCure Pharma (Sweden) is "Neurotrophin-targeted therapeutics: A gateway to cognition and more?" (Gunnar Nordvall, Pontus K. A. Larsson Forsell, Johan Sandin, 2022), with 50 citations. Next come "Topical levocabastine versus sodium cromoglycate in allergic conjunctivitis" (46) and "Hepatic insulin-degrading enzyme regulates glucose and insulin homeostasis in diet-induced obese mice" (45).

Question 2

Which research topics does AlzeCure Pharma (Sweden) publish most on?

Accepted Answer

By volume in 2022-now: Nerve injury and regeneration, Neuropeptides and Animal Physiology, Computational Drug Discovery Methods and Cancer, Stress, Anesthesia, and Immune Response.

Question 3

Which fields of science does AlzeCure Pharma (Sweden) work in?

Accepted Answer

In all years, 62% of research at AlzeCure Pharma (Sweden) is in Life Sciences, 33% in Health Sciences. Its largest fields are Neuroscience (36%), Medicine (33%), Biochemistry, Genetics and Molecular Biology (26%). It does 2.2× the world's share of Life Sciences.

Question 4

Is AlzeCure Pharma (Sweden)'s research output growing?

Accepted Answer

Output in 2022-2025 was 96% higher than in 2018-2021.